Elevance Health, Inc. (LON:0HG8)

Heartland Financial USA Statistics

Total Valuation

Elevance Health has a market cap or net worth of GBP 46.69 billion. The enterprise value is 63.11 billion.

Market Cap	46.69B
Enterprise Value	63.11B

Important Dates

The last earnings date was Wednesday, July 16, 2025.

Earnings Date	Jul 16, 2025
Ex-Dividend Date	Jun 10, 2025

Share Statistics

Current Share Class	225.18M
Shares Outstanding	n/a
Shares Change (YoY)	-2.43%
Shares Change (QoQ)	-0.62%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	224.66M

Valuation Ratios

The trailing PE ratio is 11.93 and the forward PE ratio is 9.13.

PE Ratio	11.93
Forward PE	9.13
PS Ratio	0.34
PB Ratio	1.46
P/TBV Ratio	16.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.64, with an EV/FCF ratio of 16.20.

EV / Earnings	16.13
EV / Sales	0.44
EV / EBITDA	8.64
EV / EBIT	9.56
EV / FCF	16.20

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.69.

Current Ratio	1.44
Quick Ratio	1.32
Debt / Equity	0.69
Debt / EBITDA	3.12
Debt / FCF	5.66
Interest Coverage	6.60

Financial Efficiency

Return on equity (ROE) is 12.42% and return on invested capital (ROIC) is 7.45%.

Return on Equity (ROE)	12.42%
Return on Assets (ROA)	4.65%
Return on Invested Capital (ROIC)	7.45%
Return on Capital Employed (ROCE)	11.19%
Revenue Per Employee	1.33M
Profits Per Employee	37,546
Employee Count	104,200
Asset Turnover	1.61
Inventory Turnover	n/a

Taxes

In the past 12 months, Elevance Health has paid 1.25 billion in taxes.

Income Tax	1.25B
Effective Tax Rate	24.32%

Stock Price Statistics

The stock price has decreased by -46.10% in the last 52 weeks. The beta is 0.61, so Elevance Health's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-46.10%
50-Day Moving Average	351.37
200-Day Moving Average	393.70
Relative Strength Index (RSI)	30.52
Average Volume (20 Days)	2,419

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.25

Income Statement

In the last 12 months, Elevance Health had revenue of GBP 138.14 billion and earned 3.91 billion in profits. Earnings per share was 17.07.

Revenue	138.14B
Gross Profit	37.07B
Operating Income	6.38B
Pretax Income	5.16B
Net Income	3.91B
EBITDA	6.92B
EBIT	6.38B
Earnings Per Share (EPS)	17.07

Balance Sheet

The company has 25.39 billion in cash and 22.03 billion in debt, giving a net cash position of -15.78 billion.

Cash & Cash Equivalents	25.39B
Total Debt	22.03B
Net Cash	-15.78B
Net Cash Per Share	n/a
Equity (Book Value)	32.01B
Book Value Per Share	141.94
Working Capital	14.23B

Cash Flow

In the last 12 months, operating cash flow was 4.71 billion and capital expenditures -815.30 million, giving a free cash flow of 3.90 billion.

Operating Cash Flow	4.71B
Capital Expenditures	-815.30M
Free Cash Flow	3.90B
FCF Per Share	n/a

Margins

Gross margin is 26.84%, with operating and profit margins of 4.62% and 2.83%.

Gross Margin	26.84%
Operating Margin	4.62%
Pretax Margin	3.73%
Profit Margin	2.83%
EBITDA Margin	5.01%
EBIT Margin	4.62%
FCF Margin	2.82%

Dividends & Yields

This stock pays an annual dividend of 5.12, which amounts to a dividend yield of 1.85%.

Dividend Per Share	5.12
Dividend Yield	1.85%
Dividend Growth (YoY)	4.10%
Years of Dividend Growth	7
Payout Ratio	29.98%
Buyback Yield	2.43%
Shareholder Yield	4.20%
Earnings Yield	8.38%
FCF Yield	8.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5